Response to “Use of Domperidone to Increase Breast Milk Supply: Further Consideration of the Benefit-Risk Ratio Is Required”

Abstract

Get full access to this article

View all access options for this article.

References

Paul

Zénut

Dorut

Coudoré

Vein

Cardot

Balayssac

Use of domperidone as a galactagogue drug: a systematic review of the benefit-risk ratio. J Hum Lact. 2015;31(1):57-63.

Johannes

Varas-Lorenzo

McQuay

Midkiff

Fife

Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study. Pharmacoepidemiol Drug Saf. 2010;19(9):881-888.

Olde Nordkamp

Ruwald

Goldenberg

. Syncope in genotype-negative long QT syndrome family members. Am J Cardiol. 2014;114(8):1223-1228.

Tadros

Ton

Fiset

Nattel

Sex differences in cardiac electrophysiology and clinical arrhythmias: epidemiology, therapeutics, and mechanisms. Can J Cardiol. 2014;30(7):783-792.

Seth

Moss

McNitt

. Long QT syndrome and pregnancy. J Am Coll Cardiol. 2007;49(10):1092-1098.

Varallo

Guimarães Sde

Abjaude

Mastroianni Pde

Causes for the underreporting of adverse drug events by health professionals: a systematic review [in Spanish]. Rev Esc Enferm USP. 2014;48(4):739-747.

Horen

Montastruc

Lapeyre-Mestre

Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol. 2002;54(6):665-670.

Mullard

Mediator scandal rocks French medical community. Lancet. 2011;377(9769):890-892.